BASi president, CEO and CFO Jacqueline Lemke said that the company’s approach has two important advantages over the traditional method: automation of blood sampling by Culex NxT, and monitoring of glucose levels using the Pinnacle glucose sensor with no net removal of blood from the test subjects.
"This allows researchers to take many glucose readings with no ill effects on the test subjects, resulting in more accurate glucose readings than are possible with manual sampling," Lemke added.
"BASi’s engineering team developed a new tubing set with a built-in sensor interface for the Culex NxT, allowing the placement of the sensor into the blood stream without any stress to the test subjects."
